| Literature DB >> 16996245 |
Asher Ornoy1, Rivka Wajnberg, Orna Diav-Citrin.
Abstract
In spite of a substantial increase in the use of bisphosphonates at child bearing age, very little is known regarding its use in pregnancy. We describe the outcome of 24 pregnancies after pre-pregnancy or early pregnancy alendronate therapy. Based on the pregnancy outcome it seems that alendronate does not impose a major teratogenic risk.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16996245 DOI： 10.1016/j.reprotox.2006.05.009
Source DB: PubMed Journal: Reprod Toxicol ISSN： 0890-6238 Impact factor: 3.143